People with HCV Archives – Treatment Action Group

TAG and LAT CAB Welcome Indian Patent Office Decision That Could Expand Access to Hepatitis C Treatment

May 22, 2026
Jason Kirk

TAG and the Long-Acting Therapies Community Advisory Board (LAT CAB) welcomed a decision by the Indian Patent Office rejecting a patent application related to the hepatitis C treatment combination glecaprevir/pibrentasvir (G/P). Advocates say the decision could help reduce barriers to generic competition, lower treatment costs, and expand access to hepatitis C treatment in low- and middle-income countries disproportionately affected by the epidemic.

Treatment Action Group Demands End to Political Meddling in NIH Grants

May 21, 2026
Adam Ortega

Treatment Action Group (TAG) is profoundly troubled by recent reporting that the NIH’s longstanding Notice of Funding Opportunity (NOFO) process is being interrupted and delayed by political interference.

TAG Condemns Latest U.S. “Forever” War in the Middle East, Calls for Reprogramming Billions from Military Aggression to Health and Research

March 18, 2026
Jason Kirk

TAG condemns the United States’ war in Iran and neighboring countries. At a time when U.S. investment in public health is being slashed, the Trump administration has chosen to spend billions of dollars per day on weapons used in a war of choice for which no credible rationale has been proposed. Our government should invest in our communities by spending funds that were already appropriated and illegally impounded by the White House Office of Management and Budget to keep people healthy, rather than starting new wars that put the entire world’s health at risk.

TAGLine 2025: A Year of Action

December 18, 2025
Jason Kirk

TAGLine 2025 documents a year of action as Treatment Action Group defended science, confronted attacks on public health, and fought to protect communities impacted by HIV, TB, and HCV.

New Report Urges Action to Ensure Sustainable, Affordable Supply of Key Vaccine Adjuvants for Global Health Use

December 15, 2025
Jason Kirk

Behind many lifesaving vaccines is a fragile supply chain that few people ever see. This new TAG report examines how weaknesses in the production and supply of key vaccine adjuvants (an ingredient that enhances the immune response) can create bottlenecks that threaten global access to vaccines, underscoring the importance of greater market transparency, security, and competitiveness among governments, funders, and pharmaceutical companies.

From Forest to Factory: Tracing the Supply Chains for Two Modern Adjuvants of Global Health Importance — QS-21 and MPL

December 15, 2025
Jason Kirk

From Forest to Factory: Tracing the Supply Chains for Two Modern Adjuvants of Global Health Importance — QS-21 and MPL provides a first of its kind analysis of the global supply chains of two key adjuvants used in several of the world’s most important vaccines.

TAG Condemns the ACIP Decision to Remove Birth Vaccination for Hepatitis B Virus (HBV) from Federal Guidelines, Calls for Senate Oversight Hearings and the Immediate Resignation of HHS Secretary Robert F. Kennedy, Jr.

December 8, 2025
Jason Kirk

On Friday, RFK Jr’s vaccine denialist-dominated Advisory Committee on Immunization Practices (ACIP) voted to no longer recommend immediate post-partum / birth vaccination of babies with hepatitis B virus (HBV) vaccine.

Debt and Its Impacts on TB and HIV Investment

November 18, 2025
Jason Kirk

Public financing and domestic resources for health are straining under debt burdens as countries struggle to build up domestic revenues in the face of weak tax systems and volatile markets.

TAG Profoundly Disappointed and Outraged at Lack of Healthcare Protections

November 17, 2025
Jason Kirk

Treatment Action Group (TAG) is profoundly disappointed and outraged at the lack of healthcare protections for people living with and affected by HIV, tuberculosis (TB), and hepatitis C (HCV) in the bill to end the US government shutdown.

TAG’s Comments for the September 2025 Meeting of the Advisory Committee on Immunization Practices (Docket No. CDC-2025-0454)

September 14, 2025
Jason Kirk

TAG letter urging the Advisory Committee on Immunization Practices (ACIP) to maintain the recommendation of a universal hepatitis B virus (HBV) birth dose vaccine in the United States.